Monthly Archive for May, 2008

Generic Wellbutrin XL 150mg

Teva Introduces Budeprion XL® [Bupropion Hydrochloride Extended-Release Tablets USP (XL)], 150 mg

North Wales, Pennsylvania, May 30, 2008— Teva Pharmaceuticals is pleased to announce the introduction and availability of Budeprion XL® [Bupropion Hydrochloride Extended-Release Tablets USP (XL)], 150 mg. This product is AB rated and bioequivalent to Wellbutrin XL®* Tablets. With the addition of this new strength, Teva now offers Budeprion XL® Tablets in 150 mg and 300 mg strengths, in bottle sizes of 30 and 500.

New Approvals for Late May

The FDA has approved the following products:

  • GlaxoSmithKline’s Entereg:

    Entereg (alvimopan) is a peripherally-acting mu opioid receptor (PAM-OR) antagonist designed to block the adverse side effects of opioid analgesics on the GI tract without blocking their beneficial analgesic effects.

  • Tentative approval for Teva’s Lansoprazole, the generic equivalent of Prevacid.
  • Tentative approval for both Cobalt Labs and Ivax’s Topiramate, the generic equivalent of Topamax.
  • Tentative approval for Apotex’s Escitalopram oxalate, the generic equivalent of Lexapro.

6 CEU Live Program Wednesday July 9th

Live CEU Program
Alzheimer’s, Memory, and Dementia
Presented by S. Thomas Deahl II, DMD PHD
Wednesday, July 9th 2008
8:30am to 3:30pm
Fetzer Center at WMU
Free parking, bring you own lunch or eat nearby.

Register by credit card by calling 1-800-937-6878

For more information call or email William Urfer 269-381-2256 william@swmpa.org

Preceptor Development Conference

3rd Annual Preceptor Development Conference
Ferris State University
College of Pharmacy
June 12, 2008

Grand Rapids Medical Education and Research Center
1000 Monroe Avenue
Grand Rapids, MI

5.0 credit hours (0.5 CEU)

There is no fee for this program.

Dear Colleagues,
With the advent of the Accreditation Council for Pharmacy Education (ACPE) Standards 2007, all Colleges of Pharmacy must adopt changes to their experiential programs, including an increase in hours, implementation of preceptor orientations, and provision of preceptor education. In response to Standards 2007, Ferris State University College of Pharmacy will offer an annual Preceptor Development Conference. This program is designed to provide 1) programming to assist in developing preceptor skills, 2) current information on the College of Pharmacy experiential program, and 3) CE to all adjunct preceptors and sites. I hope to see you there.
Cambria DeHoag, Pharm.D.
Associate Professor, Experiential Coordinator

For more information (PDF brochure) click here.
To register online click here.

May Meeting

SWMPA Dinner / Lecture

Thursday May 22 2008

6:30PM – Refreshments
7:00PM – Dinner and Lecture

Topic:
“Cardiovascular Updates”

Speaker:
Sandra Chase, Pharm D.

Location:

Bravo restaurant
across from the Kalamazoo-Battle Creek International Airport


View Larger Map

2 CEUs Pending

RSVP to william@swmpa.org or call William at (269)381-2256.

Kindly RSVP by May 19, 2008

Graciously sponsored by Diana Cottrell of Forest Pharmaceuticals.

NPI News – CMS

Friday, May 23, is the compliance date for inclusion of the prescriber’s national prescriber identifier (NPI) with provider claim transactions, including prescription and durable medical equipment and supplies. The Centers for Medicare & Medicaid Services has recently added a NPI-related FAQ that clarifies actions to take when the prescriber’s NPI number is missing. more

April/May NDAs

The FDA has approved the following drugs in April and May:

  • Taclonex Scalp Suspension (calcipotriene; betamethasone diproprionate) details
  • A variety of cetirizine products from various vendors continues to enter the marketplace.
  • Patanase nasal spray (olapatadine) detail
  • Treximet (sumatriptan/naproxen sodium) detail
  • Aplenzin (buproprion hydrobromide) detail